Amryt Pharma Statistics Share Statistics Amryt Pharma has 0
shares outstanding. The number of shares has increased by -0.01%
in one year.
Shares Outstanding n/a Shares Change (YoY) -0.01% Shares Change (QoQ) 0.61% Owned by Institutions (%) n/a Shares Floating 37.39M Failed to Deliver (FTD) Shares 8,646 FTD / Avg. Volume 0.36%
Short Selling Information The latest short interest is 229.45K, so 0% of the outstanding
shares have been sold short.
Short Interest 229.45K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -28.04 and the forward
PE ratio is null.
Amryt Pharma's PEG ratio is
0.32.
PE Ratio -28.04 Forward PE n/a PS Ratio 2.29 Forward PS n/a PB Ratio 1.51 P/FCF Ratio 36.42 PEG Ratio 0.32
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Amryt Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.8,
with a Debt / Equity ratio of 0.59.
Current Ratio 1.8 Quick Ratio 1.06 Debt / Equity 0.59 Debt / EBITDA 6.84 Debt / FCF 14.24 Interest Coverage -0.78
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $770.04K Profits Per Employee $-62.88K Employee Count 289 Asset Turnover 0.28 Inventory Turnover 0.92
Taxes Income Tax -11.64M Effective Tax Rate 39.05%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.76, so Amryt Pharma's
price volatility has been higher than the market average.
Beta 0.76 52-Week Price Change n/a 50-Day Moving Average 14.62 200-Day Moving Average 9.91 Relative Strength Index (RSI) 69.18 Average Volume (20 Days) 2,376,385
Income Statement In the last 12 months, Amryt Pharma had revenue of 222.54M
and earned -18.17M
in profits. Earnings per share was -0.39.
Revenue 222.54M Gross Profit 116.42M Operating Income -21.64M Net Income -18.17M EBITDA 29.1M EBIT 26M Earnings Per Share (EPS) -0.39
Full Income Statement Balance Sheet The company has 112.77M in cash and 199.18M in
debt, giving a net cash position of -86.41M.
Cash & Cash Equivalents 112.77M Total Debt 199.18M Net Cash -86.41M Retained Earnings -252.47M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 15.53M
and capital expenditures -1.54M, giving a free cash flow of 13.99M.
Operating Cash Flow 15.53M Capital Expenditures -1.54M Free Cash Flow 13.99M FCF Per Share 0.3
Full Cash Flow Statement Margins Gross margin is 52.32%, with operating and profit margins of -9.72% and -8.17%.
Gross Margin 52.32% Operating Margin -9.72% Pretax Margin -13.4% Profit Margin -8.17% EBITDA Margin 13.08% EBIT Margin -9.72% FCF Margin 6.28%
